Karoum F - Search Results

1

Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes.

Collins FA, Murphy DL, Reiss AL, Sims KB, Lewis JG, Freund L, Karoum F, Zhu D, Maumenee IH, Antonarakis SE. Collins FA, et al. Among authors: karoum f. Am J Med Genet. 1992 Jan 1;42(1):127-34. doi: 10.1002/ajmg.1320420126. Am J Med Genet. 1992. PMID: 1308352

2

Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.

Murphy DL, Sims KB, Karoum F, de la Chapelle A, Norio R, Sankila EM, Breakefield XO. Murphy DL, et al. Among authors: karoum f. J Neurochem. 1990 Jan;54(1):242-7. doi: 10.1111/j.1471-4159.1990.tb13307.x. J Neurochem. 1990. PMID: 2293615

3

Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.

Murphy DL, Sims KB, Karoum F, Garrick NA, de la Chapelle A, Sankila EM, Norio R, Breakefield XO. Murphy DL, et al. Among authors: karoum f. J Neural Transm Gen Sect. 1991;83(1-2):1-12. doi: 10.1007/BF01244447. J Neural Transm Gen Sect. 1991. PMID: 2018626

4

Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.

Lenders JW, Eisenhofer G, Abeling NG, Berger W, Murphy DL, Konings CH, Wagemakers LM, Kopin IJ, Karoum F, van Gennip AH, Brunner HG. Lenders JW, et al. Among authors: karoum f. J Clin Invest. 1996 Feb 15;97(4):1010-9. doi: 10.1172/JCI118492. J Clin Invest. 1996. PMID: 8613523 Free PMC article.

5

Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).

Murphy DL, Karoum F, Pickar D, Cohen RM, Lipper S, Mellow AM, Tariot PN, Sunderland T. Murphy DL, et al. Among authors: karoum f. J Neural Transm Suppl. 1998;52:39-48. doi: 10.1007/978-3-7091-6499-0_5. J Neural Transm Suppl. 1998. PMID: 9564606 Clinical Trial.

6

Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment.

Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Karoum F, Potter WZ, Ismond D. Zametkin A, et al. Among authors: karoum f. Arch Gen Psychiatry. 1985 Oct;42(10):969-73. doi: 10.1001/archpsyc.1985.01790330049006. Arch Gen Psychiatry. 1985. PMID: 2412521 Clinical Trial.

7

Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects.

Murphy DL, Cohen RM, Siever LJ, Roy B, Karoum F, Wyatt RJ, Garrick NA, Linnoila M. Murphy DL, et al. Among authors: karoum f. Mod Probl Pharmacopsychiatry. 1983;19:287-303. Mod Probl Pharmacopsychiatry. 1983. PMID: 6408411 No abstract available.

8

Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.

Karoum F, Potkin S, Chuang LW, Murphy DL, Liebowitz MR, Wyatt RJ. Karoum F, et al. Biol Psychiatry. 1984 Feb;19(2):165-78. Biol Psychiatry. 1984. PMID: 6713036

9

Phenylethylamine excretion in depression.

DeLisi LE, Murphy DL, Karoum F, Mueller E, Targum S, Wyatt RJ. DeLisi LE, et al. Among authors: karoum f. Psychiatry Res. 1984 Nov;13(3):193-201. doi: 10.1016/0165-1781(84)90034-9. Psychiatry Res. 1984. PMID: 6597458

10

Increased stress response and beta-phenylethylamine in MAOB-deficient mice.

Grimsby J, Toth M, Chen K, Kumazawa T, Klaidman L, Adams JD, Karoum F, Gal J, Shih JC. Grimsby J, et al. Among authors: karoum f. Nat Genet. 1997 Oct;17(2):206-10. doi: 10.1038/ng1097-206. Nat Genet. 1997. PMID: 9326944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page